title: Retinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucoma.
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Yokoyama
authors.forename: Toshiharu
authors.initials: T
authors.lastname: Choshi
authors.forename: Kenichi
authors.initials: K
authors.lastname: Kimoto
authors.forename: Kei
authors.initials: K
authors.lastname: Shinoda
authors.forename: Kazuo
authors.initials: K
authors.lastname: Nakatsuka
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D015355:Glaucoma, Neovascular / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008875:Middle Aged; D012039:Regional Blood Flow / Q000187:drug effects; D012171:Retinal Vessels / Q000187:drug effects*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab